SYNIMMUNE GMBH
SYNIMMUNE GmbH is a biotechnology company dedicated to the development of innovative and effective mono- and bispecific anti-tumor antibodies for the treatment of patients suffering from life-threatening diseases, with a focus on orphan hematopoietic malignancies. SYNIMMUNE’s lead product candidate is the antibody FLYSYN, which is currently in a first-in-human phase I clinical study in acute myeloid leukemia (AML). SYNIMMUNE GmbH is a spin-off of the Department of Immunology of the University of Tuebingen. The Company is financed by grants from the German Ministry of Education and Research (BMBF) within its GO-Bio program as well as investments by the German KfW and private equity.
SYNIMMUNE GMBH
Social Links:
Industry:
Biotechnology Clinical Trials Education
Founded:
2010-07-07
Address:
Tübingen, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.synimmune.de
Status:
Active
Contact:
+49-7071-7708381
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Analytics LetsEncrypt SSL By Default Google Universal Analytics Apache AJAX Libraries API
Similar Organizations
Geneius
Geneius is a Biotechnology company.
Genosco
Genosco is a biotechnology company.
PamGene
PamGene is an European biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.synimmune.de
- Host name: 159.89.214.161
- IP address: 159.89.214.161
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Synimmune GmbH"
Synimmune GmbH - Crunchbase Company Profile
Contact Email [email protected] Phone Number +49-7071-7708381 SYNIMMUNE GmbH is a biotechnology company dedicated to the …See details»
SYNIMMUNE (SYNIMMUNE GmbH) - Startbase
Hauptquartier: Tübingen, DE; Official Website: synimmune.de; On Social Media: Juristische Person: SYNIMMUNE GmbH Bundesland: Baden-Württemberg Übersicht Unternehmen …See details»
Synimmune 2025 Company Profile: Valuation, Investors
Synimmune General Information Description. Operator of a biotechnology company intended to facilitate the treatment of life-threatening diseases. The company is dedicated to the …See details»
SYNIMMUNE GmbH, Tübingen - Biotechnologieunternehmen
Aug 7, 2023 SYNIMMUNE GmbH mit der Handelsregisternummer HRB 734603 (Amtsgericht Stuttgart) ist seit dem 11.08.2010 aktiv. Das Unternehmen ist in der Branchen Forschung & …See details»
SYNIMMUNE GmbH, Tübingen - North Data
SYNIMMUNE GmbH. Identifikation Ut Amtsgericht Stuttgart HRB 734603 EUID DEB2609.HRB734603 Adresse Tübingen, Deutschland Gegenstand Entwicklung, die …See details»
SYNIMMUNE GmbH - Drug pipelines, Patents, Clinical trials
Explore SYNIMMUNE GmbH with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, and 10 literature, Disease Domain:Hemic and Lymphatic Diseases, …See details»
SYNIMMUNE - Overview, News & Similar companies | ZoomInfo.com
Sep 6, 2021 SYNIMMUNE GmbH is a biotechnology company dedicated to the development of innovative and effective mono- and bispecific anti-tumor antibodies for t he treatment of …See details»
Synimmune GmbH - VentureRadar
Synimmune Inc. is a biotechnology company aiming to commercialize our company’s own immune-oncology products as well as providing R&D services to partner companies that …See details»
VERAXA Biotech AG übernimmt Synimmune GmbH zur
Zürich, 29. Dezember 2023: VERAXA Biotech AG, ein Pionier in der Entwicklung fortgeschrittener Antikörper-basierter Krebstherapien und ein Portfoliounternehmen von Xlife Sciences AG …See details»
SYNIMMUNE Company Profile - Office Locations, Competitors
SYNIMMUNE is a biotechnology company dedicated to the development of mono- and bispecific anti-tumor antibodies for the treatment of patients suffering from life-threatening diseases, with …See details»
VERAXA Biotech AG übernimmt Synimmune GmbH - Walder Wyss …
29. Dezember 2023 – VERAXA Biotech AG, ein Pionier in der Entwicklung fortgeschrittener Antikörperbasierter Krebstherapien übernimmt Synimmune GmbH und dessen innovativem …See details»
SYNIMMUNE (SYNIMMUNE GmbH) - startbase.com
Official Website: synimmune.de; On Social Media: Legal Entity: SYNIMMUNE GmbH Location: Baden-Württemberg Overview Company Funding Product Team News Is this your company? …See details»
SYNIMMUNE GmbH im Startup-Atlas
Über die Firma SYNIMMUNE GmbH. Entwicklung innovativer Antikörpertherapien zur Behandlung lebensbedrohlicher Krankheiten, insbesondere hämatopoetischer Malignitäten, …See details»
Synimmune - Products, Competitors, Financials, Employees, …
Synimmune.de. Overview & Products; Financials; Founded Year 2010. Stage Acquired | Acquired. About Synimmune. Synimmune operates as a biotechnology company focusing on the …See details»
Orphanet: SYNIMMUNE
E-mail: [email protected]. SYNIMMUNE GmbH SYNIMMUNE GmbH Alte Landstrasse 42 72072 TÜBINGEN GERMANY. Phone 1: 49 (0)7071 7708381. Institution's website More …See details»
1. SYNOPSIS - uni-tuebingen.de
Synimmune GmbH Alte Landstrasse 42 15, 72072 Tuebingen Phone: +49-7071-7708381 FAX: +49-7071-7708383 Email: [email protected] Clinical Research Organization: Center for …See details»
Synimmune GmbH sold to Veraxa Biotech AG - lenzstaehelin.com
Dec 29, 2023 Synimmune GmbH, a German biotech company dedicated to the development of innovative anti-tumor antibodies was sold to Veraxa Biotech AG, a portfolio company of SIX …See details»
Synimmune GmbH - Contacts, Employees, Board Members
Synimmune GmbH is a biotechnology company. Start Free Trial . Chrome ExtensionSee details»
GenScript ProBio Enters into Agreement with SYNIMMUNE for …
Sep 6, 2021 SYNIMMUNE's lead product candidate is the FLT3 specific antibody FLYSYN, which was recently tested in a first-in-human phase I/II clinical study in AML patients. …See details»
Synimmune | CipherBio
Explore Synimmune's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»